General Information of Drug (ID: DMLK2UK)

Drug Name
RG6344 Drug Info
Indication
Disease Entry ICD 11 Status REF
Aggressive cancer 2A00-2F9Z Phase 1 [1]
Cross-matching ID
TTD Drug ID
DMLK2UK

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
BRAF V600E mutant (BRAF V600E) TT9591D BRAF_HUMAN Inhibitor [1]

References

1 Clinical pipeline report, company report or official report of Roche